India Confirms Two Nipah Virus Cases, Launches Surveillance Amid High Mortality Concerns
Two Nipah Cases in India Trigger Surveillance and Testing

India Reports Two Nipah Virus Cases, Initiates Widespread Surveillance

Two confirmed cases of Nipah virus infection have been identified in India, leading to heightened surveillance across the country and in adjoining regions. In response to these cases, Indian health authorities have conducted extensive contact tracing, identifying and testing over 190 individuals who had contact with the infected persons. All samples from these contact persons have tested negative for the virus, indicating no further spread at this time.

Expert Insights on Nipah Virus Transmission and Risks

Dr. Mahesh Kumar Manohar Lakhe, an infectious disease expert at Sahyadri Hospitals in Hadapsar, commented on the situation. He stated, "With new cases of Nipah virus infection being reported in India, it is not surprising that the general public is alarmed. Although Nipah virus disease (NiVD) is a rare condition, its high mortality rate, ranging from 40% to 75%, and periodic outbreaks make it a significant public health concern. From an infectious disease perspective, it is crucial to distinguish facts from fears and understand how the virus is transmitted, how to identify the onset of the disease, and how to protect oneself without spreading unnecessary panic."

The Nipah virus is a zoonotic pathogen, meaning it can be transmitted from animals to humans. The natural reservoir of the virus is the fruit bat, specifically the Pteropus species. Transmission occurs through the saliva, urine, and feces of infected fruit bats. Humans can contract the virus by consuming fruits contaminated with bat saliva or through direct contact with infected animals, such as pigs. After human infection, limited human-to-human transmission can occur, primarily through direct contact with body fluids of infected individuals, especially in family and healthcare settings.

Details on Recent Cases and Containment Efforts

Dr. Niladri Sekhar Das, Associate Professor and Tuberculosis Lab in-charge at the All India Institute of Medical Sciences (AIIMS) in Kalyani, provided specific details on the recent cases. He told TOI Health, "The two positive cases of Nipah virus infection identified in West Bengal were initially tested at the Virus Research and Diagnostic Laboratory (VRDL) of the Indian Council of Medical Research at AIIMS Kalyani on January 11. As of late January, one patient has shown improvement, while the other remains in critical care. Extensive contact tracing and testing of nearly 200 contacts have found no further infections, reflecting effective outbreak containment efforts. Unfortunately, since there are no licensed vaccines or specific antiviral therapies available, treatment primarily involves supportive care and strict infection control measures to prevent spread."

Detection, Diagnosis, and Surveillance Strategies

Dr. Das further elaborated on detection and surveillance methods. He added, "Detection and diagnosis of NiV rely on laboratory testing, as its early symptoms mimic other viral diseases. The gold standard method is real-time reverse transcription polymerase chain reaction (RT-PCR) performed on samples such as blood, respiratory secretions, or cerebrospinal fluid. Additional assays like ELISA may be used to detect antibodies. Because clinical signs overlap with other febrile or neurological illnesses, accurate lab confirmation is essential for appropriate management and containment. Also, some made-in-India, advanced RT-PCR point-of-care chip-based systems are capable of early detection of Nipah. Additionally, enhanced surveillance and continual infection prevention measures are recommended in coordination with central and state health authorities to keep the spread under control."

Challenges in Detecting Nipah Symptoms

Dr. Mahesh Kumar Manohar Lakhe highlighted the challenges in detecting Nipah virus symptoms. He explained, "The symptoms of Nipah virus infection, in the early stages, are often mild and non-specific, making it difficult to detect. These symptoms include fever, headache, muscle aches, weakness, sore throat, and vomiting, which are very similar to those of other viral infections. This often causes people to seek medical attention late. The incubation period is usually between four and fourteen days, but it has been known to last longer."

In some instances, the disease may progress rapidly and affect the central nervous system. Dr. Lakhe noted, "Nipah virus has a great affinity for causing encephalitis, which is inflammation of the brain. As the disease progresses, the patient may suffer from confusion, changes in mental status, severe lethargy, seizures, and in some instances, coma. There may also be respiratory problems such as breathing difficulties and pneumonia, which can result in severe illness and death. The rapid progression of the disease is one of the reasons why Nipah virus is so dangerous."

Prevention and Public Health Recommendations

Dr. Lakhe emphasized that prevention remains the best approach to protect against the Nipah virus. He urged, "Avoiding the consumption of fruits that are potentially contaminated with bat viruses, practicing good hand hygiene, and avoiding direct contact with animals in infected areas are crucial in the prevention of the disease. People who experience fever followed by neurological symptoms such as confusion or seizures should immediately consult a physician. Healthcare providers should be vigilant in preventing the spread of the disease."

He concluded with a call for informed awareness, stating, "Although the Nipah virus is a serious health threat, it is much more effective to act on informed awareness than on fear. With caution, responsible conduct, and a robust public health system, the risk can be controlled."

Medical Experts Consulted

This article includes expert inputs shared with TOI Health by:

  • Dr. Niladri Sekhar Das, Associate Professor and Tuberculosis Lab in-charge, All India Institute of Medical Sciences (AIIMS), Kalyani
  • Dr. Mahesh Kumar Manohar Lakhe, infectious disease expert, Sahyadri Hospitals, Hadapsar

Inputs were used to explain the sneaky symptoms of the Nipah virus and the deadly risks it poses.